Tighter patent rules could raise drug costs in poor countries.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Related links
Related links
Related links in Nature Research
Novartis challenges India's patent law 2012-Mar-21
Another nail in the biosimilar coffin? 2012-Mar-07
The State of the Art in the Development of Biosimilars 2012-Feb-08
Indian generics giants set sights on Japan 2011-Jun-21
'Biosimilar' drugs poised to penetrate market 2010-Nov-03
India says no to HIV drug patents 2009-Sep-03
The Morally Uncomfortable Global Drug Gap 2007-Sep-26
Related external links
US Trade Representative on the TPP
Médecins Sans Frontières brief on the TPP (PDF)
Rights and permissions
About this article
Cite this article
Maxmen, A. Trade deal to curb generic-drug use. Nature 489, 16–17 (2012). https://doi.org/10.1038/489016a
Published:
Issue date:
DOI: https://doi.org/10.1038/489016a
